logo

Sorrento Therapeutics, Inc. (SRNE)



Trade SRNE now with
  Date
  Headline
7/29/2020 9:14:43 AM Sorrento Reports License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva
7/24/2020 9:04:20 AM Sorrento Enters LoI To Acquire SmartPharm
7/20/2020 9:17:11 AM Sorrento Therapeutics Receives FDA Clearance To Initiate Phase 2 Trial Of Abivertinib In Patients With COVID-19
5/26/2020 9:10:41 AM Sorrento Therapeutics Receives FDA Clearance For Investigational New Drug Application For STI-6129
5/15/2020 11:03:28 AM Sorrento Says Anti-SARS-CoV-2 Antibody, STI-1499, Shows 100% Inhibition Of SARS-CoV-2 Virus Infection; Stock Surges
5/8/2020 9:24:10 AM Sorrento And Mount Sinai Health System To Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection
1/27/2020 7:06:19 AM Sorrento Therapeutics Unanimously Rejects Recent Acquisition Proposal
1/10/2020 7:04:44 AM Sorrento Therapeutics Gets Non-binding Proposal From A Private Equity Fund To Buy Shares Of The Company For Up To $7/Shr